SYNAPTOKINE Trademark

Trademark Overview


On Friday, September 10, 2021, a trademark application was filed for SYNAPTOKINE with the United States Patent and Trademark Office. The USPTO has given the SYNAPTOKINE trademark a serial number of 97021026. The federal status of this trademark filing is REGISTERED as of Tuesday, August 13, 2024. This trademark is owned by Suzhou Fuse Biosciences Limited. The SYNAPTOKINE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Therapeutic agents and preparations consisting primarily of biochemicals, immunoglobulin, antigen-binding fragments and cytokines for use in cancer therapies or immunotherapies; diagnostic preparations and substances for medical purposes; immunotherapies and therapeutic agents in the field of locoregionally active cytokines for medical purposes; immunotherapies, therapeutic agents, diagnostic preparations, and diagnostic substances in the field of oncology for medical purposes

Scientific research and development in the field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; scientific research and development for agents, preparations, products and technology in the fields of immunocytokines; research and development services in the field of biochemicals for scientific and medical research purposes; research and development of assays for measuring, monitoring, testing and analyzing antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments
synaptokine

General Information


Serial Number97021026
Word MarkSYNAPTOKINE
Filing DateFriday, September 10, 2021
Status700 - REGISTERED
Status DateTuesday, August 13, 2024
Registration Number7470613
Registration DateTuesday, August 13, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2024

Trademark Statements


Goods and ServicesTherapeutic agents and preparations consisting primarily of biochemicals, immunoglobulin, antigen-binding fragments and cytokines for use in cancer therapies or immunotherapies; diagnostic preparations and substances for medical purposes; immunotherapies and therapeutic agents in the field of locoregionally active cytokines for medical purposes; immunotherapies, therapeutic agents, diagnostic preparations, and diagnostic substances in the field of oncology for medical purposes
Goods and ServicesScientific research and development in the field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; scientific research and development for agents, preparations, products and technology in the fields of immunocytokines; research and development services in the field of biochemicals for scientific and medical research purposes; research and development of assays for measuring, monitoring, testing and analyzing antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 19, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSuzhou Fuse Biosciences Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressJiangsu 215128
CN

Party NameSuzhou Fuse Biosciences Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJiangsu 215128
CN

Party NameSuzhou Fuse Biosciences Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJiangsu 215128
CN

Trademark Events


Event DateEvent Description
Tuesday, September 14, 2021NEW APPLICATION ENTERED
Tuesday, October 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 15, 2022ASSIGNED TO EXAMINER
Wednesday, June 22, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 22, 2022NON-FINAL ACTION E-MAILED
Wednesday, June 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 23, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 12, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 12, 2023SOU EXTENSION 1 FILED
Thursday, October 12, 2023SOU EXTENSION 1 GRANTED
Saturday, October 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 13, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 13, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 13, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, December 13, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 30, 2024TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, February 20, 2024ASSIGNED TO PETITION STAFF
Thursday, February 22, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, February 22, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, March 13, 2024CASE RETURNED TO EXAMINATION
Wednesday, March 13, 2024NOTICE OF ALLOWANCE CANCELLED
Friday, March 15, 2024NON-FINAL ACTION WRITTEN
Friday, March 15, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, March 15, 2024NON-FINAL ACTION E-MAILED
Friday, March 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 11, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 19, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 8, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 28, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED